rs1378577 — ABCG1 ABCG1 ischemic stroke variant

Regulatory variant ~2kb upstream of ABCG1 that modulates transporter expression in macrophages; the G allele is associated with reduced risk of ischemic stroke, particularly the atherothrombotic subtype, likely through effects on HDL-mediated cholesterol clearance from arterial plaques

See your personal result for ABCG1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

ABCG1 rs1378577 — An Upstream Regulator of Plaque Stability and Ischemic Stroke Risk

When a macrophage migrates into a lipid-laden arterial wall and begins absorbing oxidized cholesterol, it faces a critical choice: offload that cargo to HDL particles and survive, or become overwhelmed by cholesterol accumulation and transform into a foam cell. This offloading depends heavily on the ABCG1 transporter11 ABCG1 transporter
ATP-binding cassette subfamily G member 1, a membrane pump that mediates cholesterol and phospholipid efflux from macrophages to mature HDL particles — the rate-limiting step in macrophage reverse cholesterol transport. When macrophage ABCG1 function is compromised, cholesterol accumulates, foam cells form, and the necrotic core of atherosclerotic plaques expands — a process that is directly linked to plaque instability and rupture, the proximate cause of most atherothrombotic strokes.

The rs1378577 variant sits approximately 2 kilobases upstream of the ABCG1 transcription start site on chromosome 21. Located in a regulatory region that influences ABCG1 expression, this T>G substitution is part of the promoter-region haplotype that has been studied in relation to ischemic stroke in Asian populations. The G allele at rs1378577 appears to be associated with reduced stroke risk — particularly the atherothrombotic subtype, which is characterized by large-artery atherosclerosis and plaque-related events.

The Mechanism

As an upstream regulatory variant, rs1378577 likely influences the binding of transcriptional regulators to the ABCG1 locus, modulating expression levels rather than altering the protein sequence directly. The ABCG1 gene on chromosome 21 is expressed widely, with particularly important roles in macrophages and monocytes that reside within arterial walls.

ABCG1 facilitates the transfer of cholesterol from macrophage plasma membranes to mature, spherical HDL particles22 ABCG1 facilitates the transfer of cholesterol from macrophage plasma membranes to mature, spherical HDL particles
this step follows ABCA1-mediated lipidation of apolipoprotein A-I into nascent HDL; the two transporters work sequentially — ABCA1 initiates the HDL particle, ABCG1 enlarges it. Reduced ABCG1 expression impairs this efflux step, leaving macrophages with excess intracellular cholesterol that promotes foam cell differentiation. ABCG1 deficiency also amplifies Toll-like receptor (TLR4) signaling in macrophages, heightening inflammatory cytokine release — a mechanism that independently accelerates plaque vulnerability independent of cholesterol level effects.

Variants in the ABCG1 promoter region that reduce transcriptional activity could therefore impair reverse cholesterol transport at the arterial wall specifically, contributing to plaque growth and instability. The nearby promoter variant rs57137919 has been confirmed by luciferase assay to alter ABCG1 promoter activity; rs1378577 is part of the same upstream regulatory haplotype and is in linkage disequilibrium with the promoter region variants studied in Chinese Han populations.

The Evidence

The primary study of rs1378577 is Li et al. 2015 (Journal of Stroke and Cerebrovascular Diseases)33 Li et al. 2015 (Journal of Stroke and Cerebrovascular Diseases), a case-control study of 389 ischemic stroke patients and 380 healthy controls in a Chinese Han population. In the overall cohort, no significant association was detected — but when stroke was subtyped, the G allele and TG+GG genotypes of rs1378577 were specifically associated with reduced risk of atherothrombotic stroke, the subtype driven by large-artery plaque rupture rather than cardioembolic or lacunar mechanisms. The association was particularly pronounced in the hypertriglyceridemic subgroup (144 cases, 115 controls), where the GG genotype was markedly less frequent among stroke patients, suggesting the G allele's protection is most evident when metabolic stress on macrophage lipid handling is highest.

Yang et al. 2022 (Gene)44 Yang et al. 2022 (Gene) studied 10 ABCA1/G1 SNPs in 249 ischemic stroke patients and 226 controls, confirming that ABCG1 variants are associated with plasma lipid differences and stroke susceptibility in this population. The studies are consistent in pointing to ABCG1's role in HDL-mediated cholesterol transport as the biological substrate linking genotype to stroke risk.

Wang et al. 2020 (Annals of Vascular Surgery)55 Wang et al. 2020 (Annals of Vascular Surgery) provided functional context by showing that ABCG1 promoter polymorphisms are associated with plasma HDL-C and LDL-C differences in Chinese Han individuals, consistent with the transporter's known role in systemic lipoprotein metabolism.

Important limitation: all published studies are from Chinese Han populations. Effect size estimates may differ in European, African, or South Asian ancestry groups. The G allele is notably more common in African populations (~50%) than European (~23%), which may reflect population-specific selection pressures and could affect how absolute risk differences translate across ancestries. Mechanistic evidence for ABCG1's role in macrophage cholesterol efflux and atherosclerosis is well-established across populations; the variant-level association requires replication in non-Asian cohorts.

Evidence level is moderate: replicated in multiple Chinese Han studies with a biologically plausible mechanism, but replication in diverse non-Asian populations is incomplete, and exact odds ratios from the abstract-available data are limited.

Practical Actions

For individuals carrying the T/T genotype (most common, ~58% globally): HDL-mediated cholesterol clearance from macrophages operates at baseline levels without the G-allele influence. Supporting ABCG1-dependent reverse cholesterol transport through specific dietary strategies — particularly increasing HDL particle function and reducing LDL oxidation exposure at arterial walls — is the most directly relevant action for this genotype.

For G/T heterozygotes: partial G-allele benefit may improve macrophage cholesterol efflux capacity and lipid profiles to an intermediate degree. Monitoring lipids and tracking HDL-C trends confirms whether the expected benefit is expressed.

For GG homozygotes: the G allele's protective association with atherothrombotic stroke is most pronounced in this genotype. This is particularly relevant in the context of elevated triglycerides, where ABCG1-dependent efflux faces the greatest metabolic challenge.

Interactions

rs1378577 is part of the same genomic region as rs57137919, an ABCG1 promoter variant associated with HDL-C, LDL-C, and CAD/stroke risk. Both variants are in linkage disequilibrium in Chinese Han populations, and their effects on ABCG1 expression are likely partially overlapping. Users carrying G alleles at both loci may experience compounded ABCG1 expression effects in macrophages.

ABCG1 works sequentially with ABCA1 in macrophage cholesterol efflux — ABCA1 (rs4149338) creates nascent HDL particles, ABCG1 (rs1378577) then loads cholesterol onto those particles. The Li et al. 2015 study examined both genes: ABCA1 variants showed opposing risk directions compared to ABCG1 variants, highlighting that dysfunction at either step in the efflux cascade can impair reverse cholesterol transport. The two-gene combination is a candidate for compound interaction analysis.

Nutrient Interactions

cholesterol altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

TT T/T — Baseline Stroke Risk Normal

Common reference genotype — no G-allele protection from ABCG1 upstream variant; standard macrophage cholesterol efflux baseline

The TT genotype means the upstream ABCG1 regulatory region carries the reference configuration at position 42,199,555 on chromosome 21. Without the G-allele modification, the ABCG1 expression pattern in macrophages follows the standard baseline. This has downstream consequences for HDL-mediated cholesterol efflux capacity and potentially for HDL particle composition and function.

In the Li et al. 2015 case-control study (PMID 25890853), the absence of the G allele (i.e., TT genotype) was overrepresented in atherothrombotic stroke patients compared to controls, particularly within the hypertriglyceridemic subgroup. The biological mechanism links to macrophage foam cell formation in arterial plaques: without the G-allele regulatory modification, ABCG1 expression may be insufficient under conditions of high lipid loading to prevent macrophage cholesterol accumulation and the subsequent plaque instability that precipitates atherothrombotic events.

Note that studies are from Chinese Han populations; quantitative risk differences may vary in European, African, or South Asian ancestry groups, though the mechanistic basis for ABCG1 function is conserved. The G allele is notably more common in African populations (~50%) than in European populations (~23%), suggesting possible population-specific selection history.

GG G/G — Strongest Protective Effect Beneficial

Two G alleles at this ABCG1 upstream regulatory locus — strongest association with reduced atherothrombotic stroke risk, particularly in people with elevated triglycerides

The GG homozygous state means both copies of the ABCG1 upstream regulatory region carry the G variant. This is predicted to produce the maximum regulatory effect on ABCG1 expression compared to the T allele configuration. In the biological framework underlying this SNP, higher ABCG1 expression in macrophages improves cholesterol efflux to HDL particles, reducing intracellular cholesterol accumulation, foam cell formation, and macrophage apoptosis within arterial plaques. The net effect is more stable plaques with smaller necrotic cores — precisely what reduces the risk of plaque rupture and subsequent atherothrombotic stroke.

The Li et al. 2015 study specifically found the GG genotype to be rare among atherothrombotic stroke patients relative to controls, with the protective effect largest in hypertriglyceridemic subjects. This interaction with triglycerides makes biological sense: elevated triglycerides challenge macrophage lipid handling by increasing the cholesterol and triglyceride burden within arterial plaques. The GG genotype's superior ABCG1 expression may provide the extra efflux capacity needed to handle this additional lipid load. Conversely, when triglycerides are well-controlled, the difference between genotypes may narrow.

Note that all data are from Chinese Han populations. The G allele frequency varies substantially by ancestry — it is relatively rare in Europeans (~23% allele frequency) but approaches 50% in African populations and ~45% in East Asians. Whether the effect size is comparable across ancestries has not been studied, though the mechanism (ABCG1-mediated reverse cholesterol transport) is conserved. Population-specific studies in European and African cohorts are needed to confirm the quantitative stroke risk reduction.

This is an association study finding with moderate evidence; the GG genotype does not eliminate cardiovascular risk — it represents a favorable modification at one regulatory locus. Monitoring lipid panels and managing modifiable risk factors (triglycerides, blood pressure, smoking) remains essential regardless of this protective signal.

GT G/T — Partial Stroke Protection Intermediate

One G allele at this upstream ABCG1 regulatory locus — partial association with reduced atherothrombotic stroke risk compared to TT homozygotes

The G/T heterozygous genotype means one ABCG1 upstream regulatory region carries the T reference allele and one carries the G allele. This codominant architecture produces an intermediate phenotype — partially benefiting from whatever regulatory influence the G allele confers on ABCG1 expression, while still carrying one T allele. In the Li et al. 2015 analysis, the GT+GG combined genotype group was significantly less frequent among atherothrombotic stroke patients than TT homozygotes, with the protective association driven by reduced macrophage cholesterol accumulation and plaque instability.

The G allele's biological effect likely involves modulation of transcription factor binding to the ABCG1 upstream regulatory region, influencing ABCG1 mRNA levels in macrophages and monocytes. Supporting the ABCG1-HDL efflux axis through dietary interventions that enhance HDL particle function can complement the partial regulatory benefit of one G allele.

All published studies are in Chinese Han populations; frequencies and effect magnitudes may differ across ancestry groups, though the G allele is common enough globally to be relevant in most populations (23–50% across ancestries).